WuXi NextCode closes $240M series B round

Genomics company WuXi NextCode Genomics Inc. (Cambridge, Mass.) raised an additional $165 million on Sept. 7 in an extension led by Sequoia China to complete a $240 million series B round. Temasek, Yunfeng Capital and 3W Partners also participated.

In May, the company raised $75 million in the initial tranche of the round co-led by Temasek and Yunfeng Capital, with participation from Amgen Ventures and 3W Partners. At the time, NextCode CEO Hannes Smarason told BioCentury, “We’re hoping that this financing and maybe one additional one will be the last round before we eventually go public” (see BioCentury, May 4)...